Clinical prognostic value of isocitrate dehydrogenase mutation, O-6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in glioma patients

BACKGROUND: Gliomas are the most frequently occurring malignant brain cancers. Recently, isocitrate dehydrogenase (IDH) mutations, O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation, and 1p/19q co-deletion have been suggested to indicate a favorable prognosis in gliomas. However, the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ann Transl Med
Главные авторы: Chen, Xi, Yan, Yuanliang, Zhou, Jianhua, Huo, Lei, Qian, Long, Zeng, Shuangshuang, Li, Zhi, Wei, Jie, Xu, Zhijie, Gong, Zhicheng
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2019
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6861750/
https://ncbi.nlm.nih.gov/pubmed/31807523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.09.126
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы